Cytokinetics Analyst Price Targets

Cytokinetics Inc

CYTKNASDAQ

$72.09

-5.81-7.46%

가까이에: Aug 28, 5:00 PM EST

$73.00

0.911.26%

시간외: 5:41 PM EST

PRO

변동 이유?:Cytokinetics shares are trading lower. The company reported pivotal Phase 3...

Wall Street analyst price targets and consensus rating for Cytokinetics (CYTK).

Price Target Range — 9 Quarters

Analyst Consensus — 21 Analysts

3S.Buy

17Buy

1Hold

Consensus RatingBuy# Analysts21Avg. Consensus PT$99Upside to Avg. PT+35.8%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 13, 2026	Barclays	Emily Field	PT Raise	Overweight	$95→$110
Aug 13, 2026	JP Morgan	Tessa Romero	PT Raise	Overweight	$97→$103
Aug 10, 2026	Truist Securities	Srikripa Devarakonda	PT Raise	Buy	$106→$112
Aug 7, 2026	RBC Capital	Leonid Timashev	PT Cut	Outperform	$117→$112
Aug 7, 2026	Citizens	Jason N. Butler	PT Raise	Market Outperform	$105→$110
Aug 7, 2026	Needham	Serge Belanger	PT Raise	Buy	$102→$112
Jul 7, 2026	RBC Capital	Leonid Timashev	PT Cut	Outperform	$119→$117
Jun 29, 2026	UBS	Ashwani Verma	Upgrade	Neutral→Buy	$69→$115
Jun 24, 2026	Mizuho	Salim Syed	PT Raise	Outperform	$100→$118
Jun 17, 2026	Needham	Serge Belanger	Maintained	Buy	$102
May 19, 2026	Citigroup	Eric Joseph	Initiate	Buy	$99
May 12, 2026	JP Morgan	Tessa Romero	PT Raise	Overweight	$92→$97
May 11, 2026	HC Wainwright & Co.	Joseph Pantginis	PT Raise	Buy	$136→$140
May 7, 2026	Wells Fargo	Yanan Zhu	PT Raise	Overweight	$95→$105
May 6, 2026	Stifel	James Condulis	PT Raise	Buy	$98→$108
May 6, 2026	Morgan Stanley	Jeffrey Hung	PT Raise	Overweight	$90→$103
May 6, 2026	RBC Capital	Leonid Timashev	PT Raise	Outperform	$101→$119
May 5, 2026	Needham	Serge Belanger	PT Raise	Buy	$85→$102
Apr 10, 2026	Wells Fargo	Yanan Zhu	Initiate	Overweight	$95
Apr 6, 2026	Barclays	Gena Wang	PT Raise	Overweight	$87→$95